Gyre Therapeutics Inc. (GYRE)
NASDAQ: GYRE
· Real-Time Price · USD
8.03
-0.19 (-2.31%)
At close: Aug 15, 2025, 2:01 PM
Gyre Therapeutics Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Product Revenue | 105.8M |
| Product Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 20.02M | 15.8M | 22.32M | 17.52M | 17.84M | 15.94M | 26.52M | 15.09M | 19.71M | 14.51M | 4.17M | 4.36M | 3.84M | 14.71M | 4.16M | 4.87M | 4.52M | 5.41M | 4.29M | 3.83M | 4.37M | 3.69M | 3.19M | 3.27M | 3.27M | 3.69M | 3.44M | 2.77M | 3.23M | 2.91M | 2.59M | 2.39M | 2.65M | 2.38M | 2.18M | 2.42M | 2.27M | 2.4M | 3.03M | 2.51M | 2.75M | 3.39M |
| Selling, General, and Administrative Revenue Growth | +26.76% | -29.23% | +27.38% | -1.77% | +11.91% | -39.89% | +75.80% | -23.47% | +35.87% | +248.31% | -4.54% | +13.50% | -73.86% | +253.22% | -14.48% | +7.77% | -16.52% | +26.30% | +11.79% | -12.31% | +18.42% | +15.56% | -2.26% | -0.06% | -11.31% | +7.02% | +24.37% | -14.11% | +10.67% | +12.68% | +8.16% | -9.91% | +11.47% | +9.27% | -10.14% | +6.73% | -5.14% | -20.88% | +20.69% | -8.70% | -18.90% | n/a |
| Research and Development Revenue | 3.42M | 3.1M | 3.71M | 2.77M | 3.35M | 2.18M | 87.67M | 3.01M | 318K | 588K | 660K | 803K | 1.87M | 9.7M | 16.14M | 20.35M | 15.39M | 17.01M | 14.56M | 12.25M | 12.91M | 13.26M | 10.79M | 9.93M | 11.11M | 12.03M | 8.24M | 5.58M | 3.89M | 3.77M | 3.56M | 3.81M | 3.4M | 2.06M | 3.11M | 3.4M | 2.75M | 2.29M | 1.77M | 1.49M | 642K | 2.34M |
| Research and Development Revenue Growth | +10.66% | -16.62% | +33.77% | -17.29% | +53.76% | -97.51% | +2813.66% | +846.23% | -45.92% | -10.91% | -17.81% | -57.08% | -80.72% | -39.86% | -20.72% | +32.25% | -9.55% | +16.88% | +18.83% | -5.09% | -2.70% | +22.89% | +8.72% | -10.66% | -7.62% | +45.98% | +47.78% | +43.35% | +3.13% | +5.90% | -6.41% | +11.88% | +65.02% | -33.77% | -8.36% | +23.40% | +20.38% | +29.45% | +18.84% | +131.46% | -72.56% | n/a |
| Sales and Marketing Revenue | 15.19M | 10.84M | 16.86M | 13.7M | 14.41M | 12.54M | 16.46M | 13.93M | 18M | 12.77M | n/a | n/a | n/a | 12.71M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | +40.15% | -35.68% | +23.05% | -4.96% | +14.93% | -23.82% | +18.21% | -22.62% | +40.97% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |